Monographie - Cefamandole nafate

Cefamandole nafate

Kémiai szerkezet

Kereskedelmi név

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Acemycin	Görögország
Cefam	Magyarország, Olaszország
Cefamandol	Luxemburg
Cefamandolo	Olaszország
Cemado	Olaszország
Kefadol	Írország
Kefandol	Marokkó, Nagy-Britannia
Lampomandol	Olaszország
Mancef	Olaszország
Mandokef	Ausztria, Görögország, Magyarország, Olaszország, Svájc
Mandol	Ausztrália, Egyesült Arab Emírségek, Hollandia, Luxemburg, új-Zéland
Mandolsan	Olaszország
Septomandolo	Olaszország
Tarcefandol	Lengyelország

Irodalom : Cefamandole nafate

	Type	Publikáció
198	Napló	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
336	Napló	Forman JK, Lachs JR, Souney PF. Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection. Am J Hosp Pharm 1987 ; 44: 1408-1409.
385	Napló	Benedict MK, Roche VF, Banakar UV, Hilleman DE. Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection. Am J Hosp Pharm 1988 ; 45: 1117-1118.
405	Napló	Nieves-Cordero AL, Luciw HM, Souney PF. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection. Am J Hosp Pharm 1985 ; 42: 1108-1109.
406	Napló	Smythe MA, Patel MA, Gasloli RA. Visual compatibility of narcotic analgesics with selected intravenous admixtures. Am J Hosp Pharm 1990 ; 47: 819-820.
418	Napló	Bosso JA, Townsend RJ. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions. Am J Hosp Pharm 1985 ; 42: 2211-2214.
472	Napló	Wohlford JG, Fowler MD. Visual compatibility of hetastarch with injectable critical-care drugs. Am J Hosp Pharm 1989 ; 46: 995-996.
574	Napló	Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ. Stability of antibiotics frozen and stored in disposable hypodermic syringes. Am J Hosp Pharm 1980 ; 37: 1087-1088.
576	Napló	Holmes CJ, Ausman RK, Walter CW, Kundsin RB. Activity of antibiotic admixtures subjected to different freeze-thaw treatments. Drug Intell Clin Pharm 1980 ; 14: 353-357.
604	Laboratórium	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
612	Napló	Frable RA, Klink PR, Engel GL, Mundell EE. Stability of cefamandole nafate injection with parenteral solutions and additives. Am J Hosp Pharm 1982 ; 39: 622-627.
630	Napló	Das Gupta V, Stewart KR. Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions. J Clin Hosp Pharm 1985 ; 10: 67-72.
999	Napló	Watson D. Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution. JPEN 1985 ; 9: 220-224.
1035	Napló	Bisaillon S, Sarrazin R. Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion. J Parenter Sci Technol 1983 ; 37: 129-132.
1047	Napló	Souney PF, Colucci RD, Mariani G, Campbell D. Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection. Am J Hosp Pharm 1984 ; 41: 323-324.
1057	Napló	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1165	Napló	Bowtle WJ, Heasman MJ, Prince AP, Easthope DA. Compatibility of the cephalosporin, cefamandole nafate with injections. Int J Pharm 1980 ; 4: 263-265.
1201	Napló	Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922.
1232	Napló	Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
1479	Napló	Digel S. Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion. Krankenhauspharmazie 1995 ; 1: 9-12.
3520	Laboratórium	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3526	Laboratórium	Clindamycin (Dalacin®) - Summary of Product Characteristics Pharmacia 2010
3546	Laboratórium	Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007
3549	Laboratórium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3594	Laboratórium	Metronidazole (Flagyl®) - Summary of Product Characteristics Zentiva 2013
3643	Laboratórium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3644	Laboratórium	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3674	Laboratórium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016